癌症化学预防:过去,现在和未来(英文)

被引：1

作者：

Michael B.Sporn

Karen T.Liby

机构：

[1] DepartmentofPharmacology,GeiselSchoolofMedicineatDartmouth

来源：

化学进展 | 2013年 / 25卷 / 09期

关键词：

化学预防; 癌症; 选择性雌激素受体调控剂; rexinoids; 三萜;

D O I：

暂无

中图分类号：

R730.1 [肿瘤的预防与控制];

学科分类号：

100214 ;

摘要：

本文将对癌症化学预防的发展历史、研究现状及其未来前景作一简要评述,主要包括以下内容:癌症化学预防的科学基础,正在使用的癌症化学预防药物,对新合成药物的需求,以及面临的挑战等。本文尤其强调了联合用药在有效的癌症预防中的重要性。

引用

页码：1421 / 1428

页数：8

共 9 条

[1]

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?[J] . Jueng Soo You,Peter A. Jones.Cancer Cell . 2012 (1)

[2]

Cancer Epigenetics: From Mechanism to Therapy[J] . Mark A. Dawson,Tony Kouzarides.Cell . 2012 (1)

[3] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas [J].

Hong, David S. ;

Kurzrock, Razelle ;

Supko, Jeffrey G. ;

He, Xiaoying ;

Naing, Aung ;

Wheler, Jennifer ;

Lawrence, Donald ;

Eder, Joseph Paul ;

Meyer, Colin J. ;

Ferguson, Deborah A. ;

Mier, James ;

Konopleva, Marina ;

Konoplev, Sergej ;

Andreeff, Michael ;

Kufe, Donald ;

Lazarus, Hillard ;

Shapiro, Geoffrey I. ;

Dezube, Bruce J. .

CLINICAL CANCER RESEARCH, 2012, 18 (12) :3396-3406

[4]

An overview of epigenetics and chemoprevention[J] . Yi-Wen Huang,Chieh-Ti Kuo,Kristen Stoner,Tim H.-Y. Huang,Li-Shu Wang.FEBS Letters . 2010 (13)

[5] Platforms and networks in triterpenoid pharmacology [J].

Sporn, Michael B. ;

Liby, Karen ;

Yore, Mark M. ;

Suh, Nanjoo ;

Albini, Adriana ;

Honda, Tadashi ;

Sundararajan, Chitra ;

Gribble, Gordon W. .

DRUG DEVELOPMENT RESEARCH, 2007, 68 (04) :174-182

[6] Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice [J].

Hingorani, SR ;

Wang, LF ;

Multani, AS ;

Combs, C ;

Deramaudt, TB ;

Hruban, RH ;

Rustgi, AK ;

Chang, S ;

Tuveson, DA .

CANCER CELL, 2005, 7 (05) :469-483

[7] Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse [J].

Hingorani, SR ;

Petricoin, EF ;

Maitra, A ;

Rajapakse, V ;

King, C ;

Jacobetz, MA ;

Ross, S ;

Conrads, TP ;

Veenstra, TD ;

Hitt, BA ;

Kawaguchi, Y ;

Johann, D ;

Liotta, LA ;

Crawford, HC ;

Putt, ME ;

Jacks, T ;

Wright, CVE ;

Hruban, RH ;

Lowy, AM ;

Tuveson, DA .

CANCER CELL, 2003, 4 (06) :437-450

[8] THE NATURE OF CANCER [J].

RINGBORG, U .

ACTA ONCOLOGICA, 1995, 34 (01) :1-1

[9]

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women .2 Andrea Z. LaCroix,Trevor Powles,C. Kent Osborne,Kevin Wolter,John R. Thompson,David D. Thompson,D. Craig Allred,Risn Armstrong,Steve R. Cummings,Richard Eastell,Kristine E. Ensrud,Paul Goss,Andrew Lee,Patrick Neven,David M. Reid,Madelyn Curto,Slobodan Vukicevic. Journal of the National Cancer Institute . 2010

← 1 →